UNSPSC 51282419: Carindacillin sodium

This classification denotes an extended spectrum penicillin antibiotic with the molecular formula C26H25N2O6S.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4OUL81K2RT, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((3-((2,3-dihydro-1h-inden-5-yl)oxy)-1,3-dioxo-2-phenylpropyl)amino)-3,3-dimethyl-7-oxo-, monosodium salt, (2s-(2alpha,5alpha,6beta))- but more generally known as carbenicillin indanyl sodium, which bears US NIH Compound Identifier 33554.

UNSPSC 51282419 Carindacillin sodium is a Commodity code nominally designating a specific pharmaceutical active ingredient, but recent state and local solicitations show minimal activity tagged to this code and the opportunities posted do not align with carindacillin procurement. The three substantive recent opportunities—a Seminole County, Florida IFB for naloxone and drug deactivation systems (posted June 30, 2026); a Texas HHS Commission RFI on direct-to-manufacturer prescription programs (posted April 3, 2026); a City of Tampa IFB for medical and first aid supplies including respiratory equipment and medical consumables for the Fire Department Rescue Division (posted March 25, 2026); and a Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP for generic multi-source pharmaceuticals and OTC products (posted January 20, 2026)—address broader pharmaceutical and medical supply procurement rather than carindacillin specifically. State and local governments use this code tier to buy emergency response medications, generic drugs through cooperative channels, and medical consumables, but the mismatch between the code's nominal scope and actual recent solicitation content signals that carindacillin itself sees little direct procurement activity at the state and local level.

The issuing bodies show a mix of county health departments, state pharmacy benefit administrators, municipal fire departments, and cooperative purchasing alliances. The geographic footprint spans Florida, Texas, Minnesota, and Oregon through cooperative arrangements, with activity concentrated in states operating formal pharmacy benefit programs or multi-jurisdictional cooperative purchasing vehicles. The Tampa IFB is sheltered for certified Small Local Business Enterprises (SLBEs) with a 5% discount capped at $10,000, and the estimated contract value is $700,000. The MMCAP RFP, effective July 1, 2026, requires manufacturers to maintain relationships with specified authorized wholesalers and comply with cGMP and DSCSA certifications, with contract terms of two years for new responders. The Seminole County procurement runs on a two-year initial term with one-year renewal option, and the Texas RFI is exploratory market research preceding a formal procurement. None of the recent opportunities explicitly procures carindacillin as a line item, indicating the code's activity at the state and local level is sparse or misfiled relative to actual pharmaceutical buying patterns.